Anzeige
Mehr »
Donnerstag, 09.10.2025 - Börsentäglich über 12.000 News
Kursrakete 2025: CiTech präsentiert sich u.a. mit DroneShield neben Palantir & Rheinmetall - welche News sind zu erwarten?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PKZC | ISIN: US0887861088 | Ticker-Symbol: 50BA
Tradegate
07.10.25 | 10:31
6,900 Euro
-2,82 % -0,200
1-Jahres-Chart
BICYCLE THERAPEUTICS PLC ADR Chart 1 Jahr
5-Tage-Chart
BICYCLE THERAPEUTICS PLC ADR 5-Tage-Chart
RealtimeGeldBriefZeit
6,9507,25014:46
6,9507,25014:13

Aktuelle News zur BICYCLE THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
08.09.Bicycle Therapeutics plc: Bicycle Therapeutics Strengthens Board of Directors with New Appointments368Roger Dansey, M.D., formerly Pfizer and Seagen, and Hervé Hoppenot, of Incyte and formerly Novartis Oncology, bring extensive drug development and commercialization expertise Bicycle Therapeutics...
► Artikel lesen
08.09.BICYCLE THERAPEUTICS PLC - 8-K, Current Report2
12.08.4 Analysts Assess Bicycle Therapeutics: What You Need To Know11
12.08.Bicycle Therapeutics stock price target lowered to $10 at Citizens JMP18
08.08.BICYCLE THERAPEUTICS PLC - 10-Q, Quarterly Report9
08.08.Bicycle Therapeutics plc: Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results414Continued advancement across research and development pipeline, with key program updates expected in 2H 2025 Phase 1/2 Duravelo-4 trial for zelenectide pevedotin in NECTIN4-amplified non-small...
► Artikel lesen
BICYCLE THERAPEUTICS Aktie jetzt für 0€ handeln
08.08.BICYCLE THERAPEUTICS PLC - 8-K, Current Report4
18.07.Demystifying Bicycle Therapeutics: Insights From 7 Analyst Reviews17
02.07.Bicycle Therapeutics plc: Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)379Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on July 1, 2025, the Compensation Committee of the company's Board of Directors granted to eight new employees inducement awards consisting...
► Artikel lesen
17.06.BICYCLE THERAPEUTICS PLC - 8-K, Current Report13
03.06.Bicycle Therapeutics plc: Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)362Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on June 2, 2025, the Compensation Committee of the company's Board of Directors granted to seven new employees inducement awards consisting...
► Artikel lesen
22.05.Bicycle Therapeutics Announces Poster Presentations at the 2025 ASCO Annual Meeting529Bicycle Therapeutics plc (NASDAQ: BCYC), a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, today...
► Artikel lesen
05.05.Bicycle Therapeutics plc: Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)415Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on May 1, 2025, the Compensation Committee of the company's Board of Directors granted to 13 new employees inducement awards consisting...
► Artikel lesen
05.05.Morgan Stanley raises Bicycle Therapeutics target to $1722
02.05.Bicycle Therapeutics stock price target cut to $22 at Citizens JMP5
01.05.Bicycle Therapeutics reports Q1 results15
01.05.BICYCLE THERAPEUTICS PLC - 10-Q, Quarterly Report1
29.04.BICYCLE THERAPEUTICS PLC - 8-K, Current Report2
29.04.Bicycle Therapeutics plc: Bicycle Therapeutics Announces Presentation of Additional Human Radiopharmaceutical Imaging Data for MT1-MMP at the American Association for Cancer Research Annual Meeting 2025359Data continue to validate the potential of MT1-MMP as a novel cancer target and further underscore the applicability of Bicycle Radioconjugates (BRC) for radiopharmaceutical imaging Data are...
► Artikel lesen
02.04.Bicycle Therapeutics plc: Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)325Bicycle Therapeutics plc (NASDAQ: BCYC), today announced that on April 1, 2025, the Compensation Committee of the company's Board of Directors granted to eight new employees inducement awards consisting...
► Artikel lesen
Weiter >>
38 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1